Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Oxycodone hydrochloride (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 5mg/5mL s/f liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 10mg/mL concentrate s/f liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely oxycodone hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 20 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 10mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 20mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 80mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 160mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely oxycodone hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 20 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin 325 mg and oxycodone hydrochloride 2.25 mg and oxycodone terephthalate 190 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen + oxycodone hydrochloride 325mg/5mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen + oxycodone hydrochloride 500mg/5mg caplets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 5 mg and paracetamol 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing oxycodone hydrochloride and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aspirin and oxycodone hydrochloride and oxycodone terephthalate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 10mg/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 10mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin + oxycodone hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely oxycodone hydrochloride 7.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 10 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 7.5 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 10 mg and paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 10 mg and paracetamol 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 7.5 mg and paracetamol 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 10 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 7.5 mg and paracetamol 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 30mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 15mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 60mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin 325 mg and oxycodone hydrochloride 2.25 mg and oxycodone terephthalate 190 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Aspirin 325 mg and oxycodone hydrochloride 2.25 mg and oxycodone terephthalate 190 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Oxycodone hydrochloride 5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 5 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxycodone hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxycodone hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 20 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 20 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 15 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 30 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 5 mg and paracetamol 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 5 mg and paracetamol 500 mg oral capsule |
Has basis of strength substance (attribute) |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 10 mg and paracetamol 325 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 7.5 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 7.5 mg and paracetamol 500 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 10 mg and paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 10 mg and paracetamol 650 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 10 mg and paracetamol 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 10 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 10 mg and paracetamol 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 7.5 mg and paracetamol 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 7.5 mg and paracetamol 300 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 10 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 10 mg and paracetamol 325 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 5 mg and paracetamol 500 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 10 mg and paracetamol 650 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 7.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 7.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Oxycodone hydrochloride 10 mg and paracetamol 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 10 mg and paracetamol 300 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 7.5 mg and paracetamol 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 7.5 mg and paracetamol 400 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 325 mg and oxycodone hydrochloride 2.25 mg and oxycodone terephthalate 190 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 160mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 20 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone hydrochloride 20 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxycodone hydrochloride 15 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxycodone hydrochloride 15 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Oxycodone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |